Consumer Defensive
USANA Health Sciences, Inc.(USNA)
Live Price
Offline$19.52
+1.83% today
1Y Change
-37.77%
Window
Jun 20, 2025 โ Jun 9, 2026
- Market Cap
- $360.00M
- Revenue Growth
- +8.3%
- EPS Growth
- -73.6%
- Dividend Yield
- 0.0%
Coverage: 243 bars ยท Jun 20, 2025 โ Jun 9, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
USANA Health Sciences, Inc. (USNA) is a Consumer Defensive stock with a market cap of $360.00M and listed on NYSE. The stock last traded around $19.52 and down 37.8% across the available one-year price window (Jun 20, 2025 โ Jun 9, 2026). Baseline metrics include revenue growth of +8.3%, EPS growth of -73.6%, a dividend yield of 0.0%. What stands out right now is revenue +8.3%, EPS -73.6%, free cash flow -83.3% with operating margin 5.5% and ROIC 2.2%. Valuation already assumes a fairly strong business story at P/E 32.9 and price/sales 0.4. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines USNA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+8.3% vs +1.7% peer median
Operating Margin
Near sector median
+5.5% vs +6.6% peer median
P/E
Above sector median
32.9 vs 14.0 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 28, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +8.3% and EPS is at -73.6%, with operating margin around 5.5%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +0.1% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 28, 2026 | โ | -4.1% | -1.3% | -3.7% |
2026 Feb 17, 2026 | +46.3% | -8.0% | +4.8% | -14.5% |
2025 Oct 21, 2025 | -160.0% | -0.6% | -3.3% | -10.8% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
USNA
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
USNA Max Drawdown
-52.30%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for USNA and SPY.
Company Overview
USANA Health Sciences, Inc.
New York Stock Exchange
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
- Leadership
- Kevin G. Guest
- IPO Date
- Apr 4, 1994
- Employees
- 1.7k
- Street Address
- 3838 West Parkway Boulevard
- Mailing
- Salt Lake City, UT, 84120
- Region
- Salt Lake City, UT, US
- Reporting Currency
- USD
- Investor Line
- 801 954 7100
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 32.9
- EV/EBITDA
- 2.2
- Price/Sales
- 0.4
- Price/Book
- 0.7
Growth
- Revenue
- +8.3%
- EPS
- -73.6%
- Free Cash Flow
- -83.3%
Profitability
- Gross Margin
- 78.3%
- Operating Margin
- 5.5%
- Net Margin
- 1.2%
- ROE
- 2.0%
- ROIC
- 2.2%
Balance Sheet
- Debt/Equity
- 0.03
- Current Ratio
- 2.24
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.